Cisplatin in high-volume intraperitoneal treatment of ovarian carcinoma
Scarabelli, C.; Campagnutta, E.; Ciarmiello, G.; Sopracordevole, F.; Nenzi, F.; Perin, A.; Miotto, E.
Minerva Ginecologica 38(7-8): 609-612
1986
ISSN/ISBN: 0026-4784 PMID: 3748441 Document Number: 272350
Document emailed within 1 workday
Related Documents
Deng, C.; Huang, R.; Lian, L. 1996: Pharmacokinetic study of intraperitoneal chemotherapy with high-dose cisplatin for advanced ovarian cancer Zhonghua Fu Chan Ke Za Zhi 31(3): 159-162Menczer, J.; Ben-Baruch, G.; Rizel, S.; Brenner, H. 1995: Intraperitoneal chemotherapy with cisplatin and etoposide in ovarian carcinoma patients who are clinically in complete remission European Journal of Gynaecological Oncology 16(1): 12-17
Topuz, E.; Saip, P.; Aydmer, A.; Salihoğlu, Y.; Berkman, S.; Bengisu, E. 1998: Intraperitoneal cisplatin-mitoxantrone and intravenous ifosfamide combination as first-line treatment of ovarian cancer European Journal of Gynaecological Oncology 19(3): 265-270
Kobayashi, H. 1985: Cisplatin and ovarian carcinoma--early detection of cisplatin-induced nephrotoxicity Nihon Sanka Fujinka Gakkai Zasshi 37(6): 888-896
Sugiyama, T.; Kumagai, S.; Nishida, T.; Ushijima, K.; Matsuo, T.; Yakushiji, M.; Hyon, S.H.; Ikada, Y. 1998: Experimental and clinical evaluation of cisplatin-containing microspheres as intraperitoneal chemotherapy for ovarian cancer Anticancer Research 18(4b): 2837-2842
Willemse, P.H.; Blom van Assendelft, P.H.; Fontein, D.L.; Kloppenburg, M.; Boonstra, H.; de Vries, E.G. 1991: Carboplatin in the treatment of ovarian carcinoma; as effective and less toxic in comparison with cisplatin Nederlands Tijdschrift Voor Geneeskunde 135(35): 1588-1592
West, R.J.; Zweig, S.F. 1997: Meta-analysis of chemotherapy regimens for ovarian carcinoma: a reassessment of cisplatin, cyclophosphamide and doxorubicin versus cisplatin and cyclophosphamide European Journal of Gynaecological Oncology 18(5): 343-348
Schiessel, R.; Funovics, J.; Schick, B.; Böhmig, H.J.; Depisch, D.; Hofbauer, F.; Jakesz, R. 1989: Adjuvant intraperitoneal cisplatin therapy in patients with operated gastric carcinoma: results of a randomized trial Acta Medica Austriaca 16(3-4): 68-69
Runhaar, E.A.; van Oosterom, A.T.; de Bruijn, E.A.; ten Bokkel Huinink, W.W. 1987: Intraperitoneal chemotherapy in ovarian carcinoma Netherlands Journal of Medicine 30(1-2): 94-103
Sorbe, B.; Hallén, C. 1991: Betamethasone-dixyrazine versus betamethasone-metoclopramide as antiemetic treatment of cisplatin-doxorubicin-induced nausea in ovarian carcinoma patients European Journal of Gynaecological Oncology 12(1): 31-37
Barker, G.H.; Wiltshaw, E. 1981: Randomised trial comparing low-dose cisplatin and chlorambucil with low-dose cisplatin, chlorambucil, and doxorubicin in advanced ovarian carcinoma Lancet 1(8223): 747-750
Marsland, T.; Griffin, T.; Ansell, J.; Hunter, R. 1981: Control of intraperitoneal haemorrhage with antifibrinolytic therapy in a patient with ovarian carcinoma Thrombosis and Haemostasis 46(2): 566
Ottevanger, P.B. 2009: Intraperitoneal chemotherapy in ovarian carcinoma. Life prolonging in selected patients Nederlands Tijdschrift Voor Geneeskunde 153(11): 503-507
Ishikawa, T.; Irie, G.; Asakawa, H.; Ikeda, M.; Dokiya, T.; Morita, K.; Inoue, T.; Masuda, K. 1990: Assessment of cisplatin in concurrent use with radiotherapy in esophageal carcinoma--joint research among nationwide multi-facilities, primary results. Research Committee for Radiation and Cisplatin Treatment of Esophageal Carcinoma Gan no Rinsho. Japan Journal of Cancer Clinics 36(1): 1-6
Ryuko, K.; Iwanari, O.; Moriyama, M.; Moriyama, M.; Nakayama, S.; Miyako, J.; Kitao, M. 1991: Intraperitoneal chemotherapy through implantable injection port in patients with advanced ovarian (or tubal) carcinoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 18(11): 2052-2057
Chiara, S.; Merlini, L.; Campora, E.; Bruzzone, M.; Giudici, S.; Rosso, R.; Ragni, N. 1993: Cisplatin-based chemotherapy in recurrent or high risk ovarian granulosa-cell tumor patients European Journal of Gynaecological Oncology 14(4): 314-317
Hosaka, M.; Ebina, Y.; Moriwaki, M.; Hara, Y.; Araki, N.; Todo, Y.; Takeda, M.; Watari, H.; Sakuragi, N. 2007: Successful desensitization using cisplatin after carboplatin-associated hypersensitivity reactions in 3 cases with recurrent ovarian carcinoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 34(9): 1505-1508
Sherman, A.I.; Rosenberg, R.; Fink, D. 1992: Use of intraperitoneal chemotherapy for treatment of ovarian cancer European Journal of Gynaecological Oncology 13(4): 295-305
Ward, B.G.; Wallace, K. 1987: Localization of the monoclonal antibody HMFG2 after intravenous and intraperitoneal injection into nude mice bearing subcutaneous and intraperitoneal human ovarian cancer xenografts Cancer Research 47(17): 4714-4718
Menczer, J.; Ben-Baruch, G.; Rizel, S.; Brenner, H. 1992: Cisplatin in combination with continuous VP16 infusion as second line chemotherapy in ovarian carcinoma. A pilot study European Journal of Gynaecological Oncology 13(4): 316-318